US009241773B2 (12) United States Patent (10) Patent No.: US 9.241,773 B2 Bolan et al. (45) Date of Patent: *Jan. 26, 2016 (54) MAGING FIDUCALMARKERS AND A61B 2019/547; A61B 2019/5408: A61B METHODS 2019/5425; A61B 2019/5454: A61B 2019/5495; A61B 2019/5458: A61B (71) Applicant: Breast-Med, Inc., Golden Valley, MN 2019/5466; G01R 33/4814; G01 R33/5601; (US) A61M31/005; A61K 49/0002: A61 K (72) Inventors: Patrick Bolan, Minneapolis, MN (US); 49/0447; A61K 49/18: A61K 49/226; Y1OT Michael G. Garwood, Medina, MN 29/4998; Y10T 29/49982; Y10T 29/49888 (US); Michael T. Nelson, Golden Valley, See application file for complete search history. MN (US); Daniel A. Halpern, St. Louis Park, MN (US) (56) References Cited (73) Assignee: Breast-Med, Inc., Golden Valley, MN U.S. PATENT DOCUMENTS (US) (*) Notice: Subject to any disclaimer, the term of this 2,678,195 A * 5/1954 Hunter et al. ..................... 74/87 patent is extended or adjusted under 35 5,016,639 A 5, 1991 Allen U.S.C. 154(b) by 0 days. (Continued) This patent is Subject to a terminal dis FOREIGN PATENT DOCUMENTS claimer. CA 2579914 A1 11/2006 (21) Appl. No.: 14/634,965 EP 1491147 A1 12/2004 (22) Filed: Mar. 2, 2015 (Continued) (65) Prior Publication Data OTHER PUBLICATIONS US 2015/O1 73848A1 Jun. 25, 2015 “U.S. Appl. No. 1 1/281,801. Examiner Interview Summary mailed Related U.S. Application Data Sep. 2, 2009, 4pgs. (63) Continuation of application No. 14/022.539, filed on (Continued) Sep. 10, 2013, now Pat. No. 8,966,735, which is a continuation of application No. 12/762,837, filed on Primary Examiner — Christopher M Koehler Apr. 19, 2010, now Pat. No. 8,544,162, which is a (74) Attorney, Agent, or Firm — Schwegman Lundberg & continuation-in-part of application No. 1 1/281,801, Woessner, P.A. filed on Nov. 17, 2005, now Pat. No. 7,702,378. (51) Int. C. (57) ABSTRACT A6B 9/00 (2006.01) An implantable tissue marker incorporates a contrast agent A6 IK 49/00 (2006.01) sealed within a chamber in a container formed from a solid (Continued) material. The contrast agent is selected to produce a change, (52) U.S. C. Such as an increase, in signal intensity under magnetic reso CPC ................. A61B 19/54 (2013.01); A61B 8/481 nance imaging (MRI). An additional contrast agent may also (2013.01); A61B 17/3468 (2013.01); be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (Continued) (CT) imaging or ultrasound imaging. (58) Field of Classification Search CPC ... A61B 8/481; A61 B 17/3468; A61B 19/54; 37 Claims, 6 Drawing Sheets v A. 6 A. US 9.241,773 B2 Page 2 (51) Int. Cl. 6,761,679 B2 7/2004 Sajo et al. A6 IK 49/04 (2006.01) 6,773,408 B1 8, 2004 Acker et al. 6,778,850 B1 8/2004 Adler et al. A6 IK 49/8 (2006.01) 6,862,470 B2 3/2005 Burbank et al. A6 IB 8/08 (2006.01) 6,927.406 B2 8/2005 Zyromski A6 IB 7/34 (2006.01) SS E3 2.58: RE:urbank et al. A6 IK 49/22 (2006.01) 7,010,340 B2 3/2006 Scarantino et al. A6M 3L/00 (2006.01) 7,044,957 B2 5/2006 Foerster et al. GOIR 33/48 (2006.01) 7,047,063 B2 5, 2006 Burbank et al. GOIR 33/56 (2006.01) 76.53.s sy 358 SARE".ag. Cal. ............ 600.414 HOIF 41/02 (2006.01) 7,702.378 B2 * 4/2010 Bolan et al. ................... 600,414 (52) U.S. Cl. 7,792,568 B2 * 9/2010 Zhong et al. .................. 600,431 CPC ........ A61K 49/0002 (2013.01); A61K 49/0447 2: 3: 833, Nissal 69; (2013.01); A61K 49/18 (2013.01); A61 K 88: 5. '58 E. N. O. 29,460 49/223 (2013.01); A61M31/002 (2013.01); 2002/0035324 A1 3/2002 Sirimanne et al. ............ 600,431 A61M31/005 (2013.01); G0IR 33/4812 2002, 0083591 A1 7/2002 GeertSma et al. (2013.01); G0IR 33/4814 (2013.01); G0IR 29:29:395). A 2992 Stegmaier et al. ... 128,899 33/5601 (2013.01); A61B 2019/547 (2013.01); 38885 A. 858 Satyal. 600/407 A61B 2019/5408 (2013.01); A61B 2019/5425 2002/0188196 A1 12/2002 Burbank et al. (2013.01); A61B 2019/5454 (2013.01); A61B 2004/003O262 A1* 2, 2004 Fisher et al. 600/S64 2019/5458 (2013.01); A61B 2019/5466 2004/0176684 A1* 9, 2004 Tabuchi et al. ... 600,424 (2013.01); A61B 2019/5495 (2013.01); HOIF 338E. A. 239: fA, (ao 600,431 41/02 (2013.01); HOIF 41/0253 (2013.01); 200402363.11. A 11/2004 Burbanket al. Y10T 29/49075 (2015.01); Y10T 29/4998 2004/0236212 A1 11/2004 Jones et al. (2015.01); Y10T 29/49888 (2015.01); Y10T 2004/0236213 A1 11/2004 Jones et al. 29/49982 (2015.01) 2005, 000445.6 A1 1/2005 Thomas et al. 2005/002091.6 A1 1/2005 MacFarlane et al. 2005, OO33157 A1 2/2005 Klein et al. (56) References Cited 2005/0059884 A1 3/2005 Kragg 2005/0059888 A1 3/2005 Sirimanne et al. ............ 600,431 U.S. PATENT DOCUMENTS 2005, OO65393 A1 3, 2005 Miller 2005, 0080337 A1* 4/2005 Sirimanne et al. ............ 600,431 5,097.839 A 3/1992 Allen 2005, 0080338 A1* 4/2005 Sirimanne et al. ............ 600,431 5,119,817 A 6/1992 Allen 2005, 0080339 A1 4/2005 Sirimanne et al. ............ 600,431 5,179,955 A 1/1993 Leveen et al. 2005/0085724 A1* 4/2005 Sirimanne et al. ............ 600,431 34::-- I A ck 38 fishereelpinger et al.a .. 378,162 2005/01542932005/0143656 A1*Al 7/20056, 2005 GisselbergBurbank et etal. al. ........... 600,420 5,397.329 A * 3/1995 Allen ............................ 378,205 2005/0205445 A1 9, 2005 Seiler et al. 5,405,402. A 4, 1995 Dye et al. 2005/023.4336 A1 10, 2005 Beckman et al. 5,469,847 A 1 1/1995 Zinreich et al. 2005/0255045 A1 1 1/2005 Woltering 5,609.850 A 3/1997 Deutsch et al. 2006/0036.165 A1 2/2006 Burbank et al. 5,702,128 A 12/1997 Maxim et al. 2006/0058,645 A1 3/2006 Komistek et al. 5,769,861. A 6/1998 Vilsmeier 2006/0058,648 A1 3/2006 Meier et al. 5,782,764 A 7/1998 Werne 2006, 00798.05 A1 4, 2006 Miller et al. 6,128,522. A 10/2000 Acker et al. 2006/0084865 A1 4/2006 Burbank et al. 6,161,034. A 12/2000 Burbank et al. 2006/O122503 A1 6/2006 Burbank et al. 6, 181960 B1 1/2001 Jensen et al. 2006, O155190 A1 7, 2006 Burbank et al. 6.269,148 B1 7/2001 Jessop et al. 2006/0173296 A1 8, 2006 Miller et al. 6,270,464 B1 8/2001 Fulton, III et al. 2006, O293581 A1 12/2006 Plewes et al. 6,333,971 B2 12/2001 McCrory et al. 2007, 0087.026 A1 4, 2007 Field 6,347,241 B2 2/2002 Burbank et al. 2007/0093726 A1 4/2007 Leopold et al. 6.350,244 B1 2/2002 Fisher 2007, 0110665 A1 5, 2007 Bolan et al. 6,356,782 B1 3/2002 Sirimanne et al. 2007, 0118034 A1 5, 2007 Mark 6,371,904 B1 4/2002 Sirimanne et al. 2007. O142725 A1 6, 2007 Hardin et al. 6,374,132 B1 4/2002 Acker et al. 2008/0033286 A1 2/2008 Whitmore et al. 6,394.965 B1 5/2002 Klein 2008/0234572 A1 9, 2008 Jones 6,405,072 B1 6/2002 Cosman 2008/0269603 A1 10, 2008 Nicoson et al. 6.427,081 B1 7/2002 Burbank et al. 2009, O105584 A1 4, 2009 Jones 6,487,438 B1 1 1/2002 Widmarket al. 2010.0030072 A1 2/2010 Casanova et al. ............. 600,431 6,516,211 B1 2/2003 Acker et al. 2010/0287887 A1 11, 2010 Bolan et al. 6,544,185 B2 4/2003 Montegrande 2013/0046164 A1 2/2013 Liu et al. 6,546,279 B1 4/2003 Bova et al. 2013/O150707 A1 6, 2013 C al 6,549,802 B2 4/2003 Thornton ima et al. 6,567,689 B2 5/2003 Burbank et al. 2013/0324946 A1 12/2013 Tobias et al. 6,575.991 B1 6/2003 Chesbrough et al. 2014/0187911 A1 7, 2014 Bolan et al. 6,605,047 B2 8/2003 Zarins et al. 6,632,176 B2 10/2003 McIntire et al. FOREIGN PATENT DOCUMENTS 6,635,064 B2 10/2003 Uetal. 6,656,192 B2 12/2003 Espositio et al. EP 1579878 A1 9, 2005 6,662,041 B2 12/2003 Burbank et al. EP 1847845 A1 10, 2007 6,699,205 B2 3/2004 Fulton, III et al. WO WO-9717103 A1 5, 1997 6,725,083 B1 4/2004 Burbank et al. WO WO-0O24332 A1 5.2000 6,730,042 B2 5/2004 Fulton et al. WO WO-0038579 A2 7, 2000 6,746,661 B2 6/2004 Kaplan WO WO-0230482 A1 4, 2002 US 9.241,773 B2 Page 3 (56) References Cited “U.S. Appl. No. 14/022,539, Final Office Action mailed Jul. 24, 2014'. 7 pgs. FOREIGN PATENT DOCUMENTS “U.S. Appl. No. 14/022,539.